COVID-19 diagnostic tests remain able to detect all published virus strains

Paris, France and Camberley, UK – 21 December 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that following the detection of a new variant of COVID-19 by the UK’s COVID-19 Genomics UK consortium, known as VUI-202012/01, the Company has carried out a detailed analysis of the mutations in

Visit Page

Launch of new private sector testing service

Novacyt, an international specialist in clinical diagnostics, announces the launch of a new service, known as VersaLab™, to support private sector testing of infectious diseases, initially focused on COVID-19.

Visit Page